Diagnostics Market Reports

Kalorama Information is your trusted source for market research on the diagnostics industry. Reports provide key industry trends, projections, and in-depth analysis for the markets you compete in. Our analysts work closely with diagnostics industry leaders to offer keen insights into consumer and institutional trends.

<< back 1 2 3 4 next >>

Title	Published	Price
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential The field of pharmacogenetics promises to open up new opportunities for the diagnostic industry at the same time it opens the door to more effective therapeutics. Pharmacogenetics is based on the principle that the effects of a given medication when administered to a patient are determined, at least in part,  |  more... Search inside this report	Oct 1, 2004	$995.00
Molecular Diagnostics for Blood Banking Applications: Testing volume, cost per test, and market potential Blood banking has been the most dynamic testing segment to adopt molecular diagnostics approaches since their introduction. Screening for HIV, HCV and HBV in donated blood, plasma and organs has largely been done by immunoassay procedures. In conjunction with background screening, this has become a very effective approach  |  more... Search inside this report	Aug 1, 2004	$995.00
U.S. Market for Molecular Diagnostics, 2nd Edition Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the  |  more... Buy by the section | Search inside this report	May 1, 2004	$3,500.00
The U.S. Market for Interventional Radiology Products Changing demographics are spurring dynamic growth in the interventional radiology market. The angioplasty balloon, coronary stent, vascular closure, and other associated equipment markets will experience healthy growth over the next 5 years. Persons over the age of 65 will be a major segment of the population  |  more... Buy by the section | Search inside this report	Apr 1, 2004	$3,500.00
Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease The recent terrorism events, in addition to the ease of travel that allows infectious diseases to spread, and technology developments drive the renewed interest in clinical and environmental infectious disease diagnostics. The combined public health and bio-terrorism markets of several bacterial and protozoan diseases are estimated to be nearly  |  more... Buy by the section | Search inside this report	Apr 1, 2004	$1,995.00
Diagnostics for Emerging Infectious Disease Threats, Volumes I - III A host of new and old infectious diseases have emerged on the world stage, presenting familiar and novel challenges to public health officials. New strains of once controlled bacteria, new immunocomprimised patient populations, and new bioterror threats have spurred diagnostics companies to develop new tests and kits to meet the  |  more...	Mar 1, 2004	$4,800.00
Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease Severe Acute Respiratory Syndrome (SARS), which was a new and unidentified disease when it first affected people, ripped through Asia and Toronto from late 2002 into the summer of 2003, before being contained for the season. Taiwan with just 346 reported cases performed 10,000 diagnostic tests. Three years  |  more... Buy by the section | Search inside this report	Dec 1, 2003	$1,496.00
Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease Diagnostic testing for prion diseases has become more important as countries increase the number of tests to battle the potential public health problem. Academic, government, and industry organizations continue to develop diagnostic testing technologies and policies as preventative measures. The number of prion diagnostic technologies being used and  |  more... Buy by the section | Search inside this report	Oct 1, 2003	$1,496.00
Successful Commercialization Strategies for New Healthcare Products and Technologies According to the Pharmaceutical Research and Manufacturers of America (PhRMA) more than 1,000 drugs are in various stages of development. Similarly, breakthroughs in the medical device arena such as coronary stents, implantable defibrillators, and minimally invasive bypass surgery and advances in DNA-based tests and other advanced diagnostics are detecting  |  more... Buy by the section | Search inside this report	Jun 1, 2003	$1,496.00
Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications Genetic testing is already in widespread use and will continue to grow in many application areas in the next five years. The number of companies offering genetic testing services and/or commercial genetic testing products continues to grow around the world. There are at least 50 companies offering genetic  |  more... Buy by the section | Search inside this report	May 1, 2003	$2,625.00
U.S. Markets in Analytical Chip Technology: Gene, Protein, Tissue, Cell, and Microbiological Microarrays The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the  |  more... Buy by the section | Search inside this report	Mar 1, 2003	$2,625.00
In Vitro Diagnostic Tests and Systems: The World Outside the United States To succeed in the diagnostics market of the 21st Century, a company has to have either a strong niche position in a particular market segment or be a jack of all trades. In either case, a full or comprehensive menu is critical. Why reinvent the wheel? Most tests  |  more... Search inside this report	Feb 1, 2003	$596.00
The Worldwide Market for Cancer Diagnostics Cancer is the number two killer disease after cardiovascular disease, worldwide. Approximately 20 million people have cancer in Japan, Europe and N. America and 10 million new cases of cancer are diagnosed each year worldwide. According to the American Cancer Society, the second-leading cause of death by disease  |  more... Buy by the section | Search inside this report	Nov 1, 2002	$3,500.00
Asian In Vitro Diagnostic Markets This report covers the five most important markets for in vitro diagnostics in Asia: Japan, China, India, Korea and Taiwan. The total market for diagnostics is broken down into six segments: Routine chemistry, critical care chemistry, hematology, urinalysis, coagulation and immunochemistry. The instruments working in each  |  more... Buy by the section | Search inside this report	Oct 1, 2002	$2,625.00
Gene Amplification Technologies: End Users, Marketers, and Markets Gene amplification technology has been a backbone technology for the Human Genome Project and is vital in other fields, such as diagnostics. There are more than 50 biotech and diagnostic companies with DNA amplification technology and approximately 30 different gene- and signal-amplification technologies, from polymerase chain reaction to ligase  |  more... Buy by the section | Search inside this report	Aug 1, 2002	$3,000.00
The Worldwide Market for In Vitro Diagnostic Tests - 3rd Edition This comprehensive report is a thorough overview of the in vitro diagnostics (IVD) industry worldwide, covering the breadth of traditional IVD testing (Kalorama released a report dedicated to the molecular diagnostics segment in the Fall of 2001). The Worldwide Market for In Vitro Diagnostic Tests will contain complete market statistics  |  more... Buy by the section | Search inside this report	Apr 1, 2002	$2,625.00
Advanced Polymers for Medical Applications: Materials, Product Development, and Market Opportunities In virtually all areas of medicine, increasingly sophisticated devices are turning to increasingly sophisticated materials science to solve their most nagging technical problems. From passive functions like sterility and biocompatibility to active drug delivery and even conductivity, polymers are proving to be more versatile and complex than ever before. Kalorama's  |  more... Buy by the section | Search inside this report	Feb 1, 2002	$2,625.00
Diabetes and Diabetic Complications: Major World Markets The global market for diabetes products, particularly new therapeutics and monitoring products, is a large and growing one. This growth is fueled by three factors --- (1) a rapidly increasing patient population; (2) a back-log of unmet needs, particularly with regard to therapeutics; and (3) advances in biomedical  |  more... Buy by the section | Search inside this report	Jan 1, 2002	$2,625.00
Trends in the Early Diagnosis of Cardiovascular Disease: Worldwide Market Opportunities Despite dramatic improvements in both diagnosis and therapy, cardiovascular disease remains the leading cause of mortality in the developed world. Worldwide more than $54 billion was spent on cardiac care therapeutics in 1999, with an expected 10% annual increase for the next 10 to 15 years. Furthermore, U.S. government statistics  |  more... Buy by the section | Search inside this report	Oct 1, 2001	$3,250.00
The U.S. Market for Molecular Diagnostics In recent years molecular diagnostics has become a growing part of the clinical laboratory. The trend will not only continue but will show significant growth in the future. This report from Kalorama Information examines the current and future opportunities associated with Molecular Diagnostic Technologies. Areas covered include: Applications  |  more... Buy by the section | Search inside this report	Oct 1, 2001	$2,750.00
MarketLooks: Opportunities in Immunotherapy MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for use in presentations  |  more...	Apr 1, 2001	$399.00
Current Developments in Immunotherapy Markets and Technology Beyond congenital and acquired immune deficiencies immunotherapy is employed in a number of major disease areas such as hypersensitivity/allergy and cancer. The application in organ transplantation dealing with prevention of allograph rejection and transplantation sickness has long been known. This report from MarketResearch.com examines this market and provides forecasts to  |  more... Buy by the section | Search inside this report	Apr 1, 2001	$2,812.00
MarketLooks: The Market for Rapid Diagnostic Tests for Portable Blood Analyzers MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for use in  |  more...	Jan 1, 1999	$299.00
MarketLooks: The Market for Rapid Diagnostic Tests for Cardiovascular Diseases MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for use in  |  more...	Jan 1, 1999	$299.00
MarketLooks: The Market for Rapid Diagnostic Tests for Therapeutic Drug Monitoring MarketLooks are concise, graphic-rich summaries of full-length market research reports. Reports that cover more than one market segment are split into corresponding MarketLooks to allow you to purchase only what you need. All MarketLooks are created in PowerPoint(R) for easy extraction of text, charts and tables for use in  |  more...	Jan 1, 1999	$299.00
Title	Published	Price

<< back 1 2 3 4 next >>